Endocrine Flashcards

1
Q

Congenital hypothyroidism

A

Decreased T4 levels

  • Endemic Cretinism= insufficient iodine in utero
  • Sporadic= defect in T4 formation in utero, developmental thyroid formation failure

Symptoms:
- Lethargy, poor feeding
- Jaundice, macroglossia
- Constipation, umbilical hernia, myxedema
- Muscle hypotonia, hoarse cry
- ASD, VSD
Pot bellied, Pale, Puffy-faced child with Protruding umbilicus, protuberant tongue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Somatomedin C

A

AKA IGF-1= insulin-like growth factor 1

  • GH Secreted by pituitary–> liver produces IGF-1
  • induces chondrocytes to proliferate along epiphyseal plate (long bone growth!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fetal adrenal gland

A

Outer zone= adult zone

  • No function until late in gestation: begins secreting cortisol
  • Controlled by ACTH and CRH from fetal pituitary and placenta
  • Cortisol–> fetal lung maturation and surfactant secretion

Inner zone= Active fetal zone

  • Produces androgens with placenta
  • Lacks 3-beta-hydroxysteroid to convert pregnolone–> progesterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anterior pituitary

A

Secretes FSH, LH, ACTH, TSH, prolactin, GH, MSH

  • Derived from oral ectoderm (Rathke’s pouch–> craniopharyngioma) vs posterior pituitary= neuroectoderm
  • Alpha subunit= TSH, LH, FSH, hCG common subunit
  • Beta subunit= hormone-specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

GLUT-1 receptors

A

Insulin INDEPENDENT

- RBCs, Brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GLUT-2 receptors

A

Bidirectional

  • Beta-islet cells
  • Liver, kidney, small intestine (insulin-independent uptake)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GLUT-4 receptors

A

Insulin DEPENDENT

  • Adipose tissue
  • Skeletal muscle
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Insulin release

A

Beta cells in pancreas: center of islet

  1. GLUT-2 transporter brings in glucose
  2. Glycolysis in Beta cell–> ATP/ADP ratio increase
  3. ATP binds and closes K+ channels
  4. Membrane depolarizes
  5. Ca+2 influx into beta cell
  6. Exocytosis of insulin granules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glucagon release

A

Alpha-cells in pancreas: periphery of islet

Secreted in response to:

  • Hypoglycemia
  • Increased serum [amino acids]
  • Adrenergic stimulation (epi–> alpha2 receptors)
  • CCK
  • Ach

Inhibited by:

  • Insulin
  • Hyperglycemia
  • Somatostatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

17-alpha-hydroxylase deficiency

A

Hypertension, hypokalemia

Males: decreased DHT–> pseudohermaphroditism (ambiguous genitalia, undescended testes

Females: internally and externally phenotypic female lacking secondary sex characteristics

**Enlarged adrenal glands d/t increased ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

21-hydroxylase deficiency

A

HYPOtension, hyperkalemia, increased renin activity, volume depletion

Females: masculinization; pseudohermaphroditism

**Enlarged adrenal glands d/t increased ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

11-beta-hydroxylase deficiency

A

HYPERtension:

  • increased 11-deoxycorticosterone= mineralocorticoid, secreted in excess (HTN)
  • Decreased aldosterone

Females: Masculinization

**Enlarged adrenal glands d/t increased ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Growth Hormone

A

Anterior pituitary

Stimulates linear growth:
- increases liver IGF-1/somatomedin C secretion–> - induces chondrocytes to proliferate along epiphyseal plate (long bone growth)

Increased secretion in exercise, sleep
- Inhibited by glucose, somatostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cortisol

A

Adrenal zona fasciculata, bound to corticosteroid-binding globulin (CBG)

  • Maintains BP (upregulates alpha1 receptors on arterioles–> increased sensitivity to NE, epi
  • Decreases bone formation
  • Anti-inflammatory/immune suppressive (blocks IL-2, etc)
  • Increased insulin resistance
  • Increased gluconeogenesis, lipolysis, proteolysis
  • Inhibits fibroblasts–> striae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PTH

A

Secreted by chief cells in parathyroid

Regulated by:

  • depleted Ca+2–> increased PTH
  • Decreased Mg+2–> increased PTH
  • Absent Mg+2–> decreased PTH (needs Mg+2 for manufacuring in chief cells); can be caused by diarrhea, aminoglycosides, diuretics, alcohol abuse

MOA:

  • Stimulates cAMP–> increased osteoblastic RANK-L + M-CSF expression–> increased osteoclast activity
  • Decreases osteoprotegerin release (OPG= inhibitor at RANK-L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

cAMP signaling hormones (Gs/Gi)

A
Releasing hormones:
FSH
LH--> leydig (testosterone)/ Corpus luteum (progesterone)
SCT
TSH
CRH
hCG
ADH (V2 receptor)
MSH
PTH
Calcitonin
GHRH
Glucagon
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

cGMP signaling hormones

A

Vasodilators:

ANP
NO (endothelial derived relaxing factor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IP3 signaling hormones (Gq)

A
GnRH
GHRH
Oxytocin
ADH
TRH
Histamine (H1)
Angiotensin II
Gastrin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Steroid receptor

A
Vitamin D
Estrogen
Testosterone
T3/T4
Cortisol
Aldosterone
Progesterone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Intrinsic tyrosine kinase

A

Growth factors:

Insulin
IGF-1
FGF
PDGF
EGF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Receptor-associated tyrosine kinase (JAK/STAT)

A

Prolactin
Immunomodulators (cytokines, IL-2,6,8, IFN)
GH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Sex hormone binding globulin (SHBG)

A

Binds sex hormones:

Men: increased SHBG–> decreased free T–> gynecomastia

Women: decreased SHBG–> increased free T–> hirsutism
- SHBG increased in pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Thyroid hormone function

A
  1. bone growth (synergism with GH)
  2. CNS maturation
  3. increases B1 receptors in heart
  4. increases BMR (basal metabolic rate)
  5. increases glycogenolysis, gluconeogenesis, lipolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Thyroid hormone production

A
  1. Iodine (I-) uptaken from blood by follicular cell
  2. TPO (Thyroid Peroxidase) oxidizes I- –> I2
  3. Follicular cell secretes I2, thyroglobulin into lumen (colloid)–> MIT/DIT
  4. Peroxidase (TPO) in lumen couples MIT/DIT–> T3/T4
  5. T3/T4 re-imported into follicular cell–> proteolysis–> released into blood (bound to TBG= thyroid binding globulin)
    - TBG increased by estrogen, decreased by liver failure
    - T4= major product; converted by 5’-deiodinase in periphery to active T3
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Wolff-Chaikoff effect

A

Excess iodine temporarily inhibits TPO
(thyroid peroxidase)
–> decreased iodine organification
–> Decreased T3/T4 production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Propylthiouracil

A

PTU
MOA:
- blocks TPO formation of T3/T4
- Blocks 5’deiodinase conversion of T4–> T3

Tox: skin rash, agranulocytosis, aplastic anemia, hepatotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Methimazole

A

MMI
MOA; blocks TPO formation of T3/T4

Tox: skin rash, agranulocytosis, aplastic anemia, teratogen?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Dexamethasone suppression test

A

Normal function: cortisol suppressed by low dexamethasone

ACTH-pituitary tumor (Cushing’s): suppressed by high dexamethasone

  • Also can take venous sample of petrosal sinus
  • 24 hour urine collection: free cortisol 3x upper limit of normal

Ectopic ACTH-producing tumor (SCLC, bronchial carcinoids)/ Cortisol-producing tumor (adrenal adenoma): remains elevated with high dose dexamethasone

29
Q

Conn’s syndrome

A

Aldosterone-secreting adrenal adenoma

  • Hypertension, Hypokalemia (like 17-alpha-hydroxylase deficiency)
  • Metabolic alkalosis
  • low plasma renin

Symptoms:

  • HTN
  • Weakness, paresthesias (hypoklemia)

Bilateral or unilateral

Treatment:

  • Surgery to remove tumor
  • Spironolactone (aldosterone antagonist)
30
Q

Secondary hyperaldosteronism

A

Low perfusion in kidney (d/t renal artery stenosis, chronic renal failure, CHF, cirrhosis, nephrotic syndrome)
–> increased renin production

Treatment:
- Spironolactone

31
Q

Addison’s disease

A

Chronic primary adrenal insufficiency
- Adrenal atrophy/destruction of adrenals (autoimmune- increased risk with T1DM, TB, metastasis)

Deficiency of aldosterone, cortisol

  • Hypotension (hyponatremic volume contraction)
  • Hyperkalemia
  • Acidosis
  • Skin hyperpigmentation (MSH: increased ACTH–> MSH increase from POMC)

Treatment: Corticosteroids

32
Q

Secondary adrenal insufficiency

A

Decreased pituitary ACTH

  • No skin hyperpigmentation
  • no hyperkalemia

Tx: responds to ACTH

33
Q

Pheochromocytoma

A

Tumor of adrenal medulla in ADULTS
- Chromaffin cell (neural crest)

Secretes epi, NE, DA–> episodic HTN

Labs:

  • Increased urinary VMA (breakdown product of NE, epi)
  • Increased plasma catecholamines

Associated with:

  • NF-1
  • MEN 2A, 2B

Treatment:

  • Alpha-antagonist (irreversible): pheoxybenzamine (avoid hypertensive crisis)
  • Beta blocker: slow HR
  • Surgical removal

rule of 10s (10%): malignant, bilateral, extra-adrenal, calcify, kids

34
Q

Neuroblastoma

A

MOST Common Tumor of adrenal medulla in children

Presentation:

  • Opsoclonus-myoclonus syndrome= non-rhythmic conjugate eye movements + myoclonus
  • Retroperitoneal mass, anorexia, weight loss
  • Less likely to see HTN
  • elevated HVA in urine (catecholamines)

Histo:

  • Solid sheets of small blue round cells
  • Can occur anywhere along sympathetic chain

**Overexpression of N-myc–> rapid tumor progression (transcription factor)

35
Q

Hashimoto’s thyroiditis

A

anti-TPO, antithyroglobulin antibodies

  • HLA-DR5
  • Increased risk of non-Hodgkin’s lymphoma
  • Normal ESR
  • Chronic, progressive

Histo:

  • Hurthle cells
  • Lymphocytic infiltrate with germinal centers
  • Enlarged, nontender thyroid
36
Q

Subacute thyroiditis (de Quervain’s)

A

Self-limited hypothyroidism after flu-like illness

Histo: granulomatous inflammation

  • Neutrophils: lymphocytes, histiocytes, multi-nucleated giant cells (granuloma)
  • disrupted follicles around collioid

Findings:

  • Increased ESR, jaw pain, early inflammation, tender thyroid
  • Thyrotoxic–> hypothyroid–> euthyroid

Tx: NSAIDs for pain

37
Q

Riedel’s thyroiditis

A

Thyroid replaced by fibrous tissue (hypothyroid)

Findings:

  • Fixed, hard (rock-like) painless goiter
  • May extend into surrounding tissue
    • Manifestation of IgG4-related systemic disease (autoimmune pancreatitis)
38
Q

Hypothyroid myopathy

A

Pale muscle fibers with:

  • decreased striation
  • deposition of mucinous material
  • atrophy of Type II mucle fibers

Symptoms:

  • Weakness
  • Fatiguability
  • Muscle pain, cramping
39
Q

Toxic multinodular goiter

A

Focal patches of hyperfunctioning follicular cells

  • Work independently of TSH (mutation in TSH receptor)
  • Increased release of T3, T4

Jod-Basedow phenomenon= thyrotoxicosis after repletion of iodine deficency

40
Q

Grave’s disease

A

Diffusely enlarged goiter secreting TSI (thyroid-stimulating immunoglobulins)–> autoimmune hyperthyroidism

  • Proptosis (opthalmopathy, EOM swelling)
  • Pretibial myxedema
  • Increase in connective tissue deposition

Stress-induced (Childbirth)

41
Q

Thyroid Storm

A

Thyrotoxicosis:

  • Stress-induced catecholamine surge–> death by arrhythmia
  • Serious complication of Grave’s, hyperthyroid disorders

Increased ALP d/t increased bone turnover

Tx:

  • Glucocorticoids for exopthalmos
  • Beta-blockers for relief of sympathetic activation
  • Block iodine organification (Iodide salts, Propylthiouracil, Methimazole)
  • Radioactive iodine (ablate thyroid with I-131)
42
Q

Primary hyperparathyroidism

A

Adenoma–> Hypercalcemia

  • Hypercaluria, hypophosphatemia
  • Increased PTH, alk phos, cAMP in urine
  • Weakness, constipation

Osteitis fibrosa cystica= cystic bone spaces with brown fibrous tissue (bone pain)

43
Q

Secondary hyperparathyroidism

A

Decreased gut Ca+2 absorption, increased phosphate
- Chronic renal disease (hypovitaminosis D–> decreased Ca+2 absorption)

Hypocalcemia, hyperphosphatemia in chronic renal failure (decreased phosphate in other causes)
- Increased alk phos, PTH

Renal osteodystrophy= bone lesions d/t secondary/tertiary hyperpara

44
Q

Tertiary hyperparathyroidism

A

Refractory (autonomous) hyperparathyroidism d/t chronic renal disease

VERY elevated PTH, elevated Ca+2

45
Q

Albright’s hereditary osteodystrophy

A

AD: kidney unresponsive to PTH

  • -> hypocalcemia,
  • shortened 4th/5th digits
  • short stature
  • Resistance to TSH, LH, FSH (all stimulate Gs alpha pathway)
46
Q

Acromegaly

A

Pituitary adenoma–> excess GH

  • Large tongue, deep furrows
  • Deep voice
  • Large hands, feet, coarse faces
  • Impaired glucose tolerance

Diagnosis:

  • Increased serum IGF-1
  • fail to suppress serum GH after oral glucose tolerance test

Tx: resect adenoma, somatostatin analog if not cured

47
Q

Causes of diabetes insipidus

A
Central: lack ADH
- Pituitary tumor
- Trauma
- Surgery
- Langerhans cell Histiocytosis
Treatment: intranasal Desmopressin

Nephrogenic= kidney doesn’t respond to ADH
- hereditary
- secondary to hypercalcemia
- Lithium
- Demeclocyline (ADH antagonist)
Treatment: HCTZ, indomethacin (NSAID), amiloride

48
Q

SIADH

A

Causes:

  • Ectopic ADH (SCLC)
  • CNS/head trauma
  • Pulmonary disease
  • Drugs (cyclophosphamide)
Treatments:
Fluid restriction
IV saline
Conivaptan
Tolvaptan
Demeclocycline
49
Q

Maternal diabetes

A

Insulin must be given to control blood glucose (insulin does not cross placenta)

Poor control

  • Hypoglycemia of newborn (beta islet cell hyperplasia due to excess glucose exposure in utero)
  • Caudal regression syndrome (sacral agenesis–> lower extremity paralysis, urinary incontinence)
  • Transposition of the great vessels
50
Q

Glucagonoma

A

Pancreatic tumor (rare)

Presentation:

  • Migratory erythema
  • Hyperglycemia (diabetes)
  • Stomatitis, chelosis
  • Abdominal pain
51
Q

VIPoma

A

Pancreatic tumor

Presentation:

  • Diarrhea
  • Metabolic acidosis
  • Hypokalemia
52
Q

Somatostatinoma

A

Pancreatic delta cell tumor

Presentation:

  • Abdominal pain
  • Gallstones
  • Constipation
  • Steatorrhea

Labs:

  • Decreased insulin, glucagon, CCK, secretins
  • Decreased gastric motility
53
Q

Carcinoid syndrome

A

Carcinoid tumor= neuroendocrine cells

  • Metastatic small bowel tumor secreting 5-HT (most common tumor of appendix)
  • Only seen if tumor metastasizes from bowel (5-HT digested in liver)

Symptoms:

  • Recurrent diarrhea
  • Cutaneous flushing
  • Asthmatic wheezing
  • Right-sided valvular disease
  • Increased serotonin in urine
  • Niacin deficiency

Treatment: Somatostatin analog (octreotide)

54
Q

MEN 1

A

Werner’s syndrome: Autosomal Dominant
DIAMOND; 3Ps

  • Pituitary tumor
  • Parathyroid tumors
  • Pancreatic endocrine tumors (Zollinger-Ellison, insulinoma, VIPoma, glucagonoma)

Presentation: kidney stones, stomach ulcers

55
Q

MEN 2A

A

Sipple’s syndrome: Autosomal Dominant
SQUARE: 2 Ps

  • Parathyroid tumors: 3rd/4th pharyngeal pouch
  • Pheochromocytoma
  • Medullary thyroid carcinoma (calcitonin): 4th/5th pharyngeal pouch

** ret gene mutation (tyrosine kinase)

56
Q

MEN 2B

A

Autosomal dominant
TRIANGLE: 1 P

  • Oral/intestinal ganglioneuromatosis (marfanoid habitus)
  • Medullary thyroid carcinoma (calcitonin)
  • Pheochromocytoma

** ret gene mutation (tyrosine kinase)

57
Q

Metformin

A

Biguanide
MOA: unknown;
- decreases gluconeogensis
- increases glycolysis, peripheral glucos uptake

Oral: 1st line in T2DM

Tox:

  • GI upset
  • Lactic acidosis (contraindicated in renal failure)
58
Q

Tolbutamide, chlorpropamide

A

Sulfonylureas (1st generation)
MOA: close K+ channel in Beta cell membrane (like ATP)–> cell depolarizes–> Ca+2 influx–> insulin release

Only for T2DM

Tox: Disulfiram-like effects

59
Q

Glyburide
Glimepiride
Glipizide

A

Sulfonylureas (2nd generation)
MOA: close K+ channel in Beta cell membrane (like ATP)–> cell depolarizes–> Ca+2 influx–> insulin release

Only for T2DM

Tos: hypoglycemia

60
Q

Pioglitazone, Rosglitazone

A

Glitazones/thiazolidinediones
MOA: Binds PPAR-gamma nuclear transcription regulator–> increased insulin-responsive genes–> increased insulin sensitivity in peripheral tissue

Mono or combo in T2DM

Tox:
- Weight gain, edema, hepatotoxic, heart failure

61
Q

Acarbose, miglitol

A

Alpha-glucosidase inhibitors

MOA: inhibit intestinal brush-border alpha-glucosidases–> delayed sugar hydrolysis, glucose absorption

Mono or combo in T2DM

Tox: GI disturbances

62
Q

Pramlintide

A

Amylin analog

MOA: decreases glucagon

T1 and T2DM

TOx: hypoglycemia, nausea, diarrhea

63
Q

Exenatide, Liraglutide

A

GLP-1 analogs

MOA: increased insulin, decreased glucagon release

T2DM

Tox: N/V, pancreatitis

64
Q

Linagliptin
Saxagliptin
Sitagliptin

A

DPP-4 inhibitors

MOA: increased insulin, decreased glucagon release

T2DM

Tox: urinary, respiratory infections

65
Q

Somatostatin

A

Octreotide

Use: acromegaly, carcinoid tumor
gastrinoma, glucagonoma, esophageal varices

66
Q

Demeclocyline

A

Tetracycline, ADH antagonist

Use: SIADH

Tox:

  • Nephrogenic DI
  • Photosensitivity
  • Abnormalities of bone, teeth
67
Q

Basal insulin types

A

NPH (2 times/day)

Glargine, Detemir (1x/day)

68
Q

Post-prandial insulin

A

Regular: peaks 2-4 hours after administration
- use IV in DKA

Lispro, aspart, glulisine: peak 45 minutes after administration
- Use to prevent post-meal hyperglycemia

69
Q

T2 Mature onset diabetes of the young (MODY)

A

Defect in Glucokinase enzyme (specific to liver, pancreatic beta-cells)- has high Km
- Can also have defect in transcription factors for insulin